Trial intelligence / Profile preview

Novel In Situ Caries and ETW Models Development: Safety and Validation Study

NCT07849270Phase 3Active, not recruiting

Sponsor
Indiana University
Start
Aug 2026
Primary completion
Jan 2027
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of sodium fluoride in dental caries and erosive tooth wear (ETW) (3 arms), sponsored by Indiana University. Primary endpoints: Mean Percent Surface Microhardness Recovery at 21 days and Surface Loss at 21 days. Started Aug 2026; status: active, not recruiting.

02

Drugs

sodium fluoride
03

Conditions

dental carieserosive tooth wear (ETW)

Beyond the preview

Go deeper on NCT07849270.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07849270.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call